论文部分内容阅读
分析１０ 例卵巢支持－ 间质细胞瘤（ Ｓ Ｌ Ｃ Ｔ） 患者的临床资料。结果： Ｓ Ｌ Ｃ Ｔ 占所有卵巢肿瘤的０ ．９ ％ ，占卵巢性索－ 间质瘤的１０ ．３ ％ 。平均年龄３４ ．１ 岁，多发生于单侧卵巢。５０ ％ 伴有腹水，７０ ％ 有男性化表现。从出现临床症状到发现盆腔包块时间约１ ～４ 年，临床Ⅰ期占９０ ％ 。讨论了 Ｓ Ｌ Ｃ Ｔ 的组织来源及病理分型，证实 Ｓ Ｌ Ｃ Ｔ 有类固醇激素分泌功能，早期诊断困难，需动态监测卵巢功能及形态，治疗以手术为主，术后辅以化疗。预后与临床分期及分化程度有关，早期复发为其特点，术后重视男性化或／ 和血清睾丸酮水平升高是复发标志。
The clinical data of 10 patients with ovarian support-stromal tumor (S L C T) were analyzed. Results: S L C T accounts for 0 for all ovarian tumors. 9 %, accounting for ovarian cord - stromal tumors 10. 3%. The average age of 34. At the age of 1, most of them occur in unilateral ovaries. 50% were accompanied by ascites and 70% had masculine performance. From clinical symptoms to the discovery of pelvic masses for about 1 to 4 years, clinical stage I accounts for 90%. The tissue source and pathological classification of S L C T were discussed. It was confirmed that S L C T had steroid hormone secretion function and it was difficult to diagnose early. It was necessary to dynamically monitor ovarian function and morphology. The treatment was mainly surgery, and postoperative chemotherapy was supplemented. Prognosis is related to clinical stage and differentiation. Early recurrence is its characteristic. Postoperative masculinization and/or elevation of serum testosterone levels are markers of recurrence.